NCT06061874View on ClinicalTrials.gov

Ga68-FAPI-46 PET/CT for Preoperative Assessment of Peritoneal Carcinomatosis

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 30, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
CancerPeritoneal Carcinomatosis
Interventions
DIAGNOSTIC_TEST

FAPI PET/CT

The radiopharmaceutical 68Gallium-FAPI-46 (FAPI) is applied intravenously for molecular imaging of FAP expression with FAPI PET/CT.

Trial Locations (1)

Unknown

RECRUITING

Institut Jules Bordet, Brussels

Sponsors
All Listed Sponsors
lead

Jules Bordet Institute

OTHER